News

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen, MVA-based vaccines and solid tumor immunotherapies, today issued a statement in response to the U.S.
The Amarillo City Council met Tuesday through Thursday for budget workshops. The City of Amarillo staff presented the ...